Review Article
Off-label uses of etanercept in dermatology
Usos no aprobados de etanercept en Dermatología
Andrés Tirado-Sáncheza,b,
, Victoria de la Fuente-Garcíaa, Rosa María Ponce-Oliveraa
Corresponding author
atsdermahgm@gmail.com
Corresponding author at: Departamento de Dermatología, Hospital General de Zona 29, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Corresponding author at: Departamento de Dermatología, Hospital General de Zona 29, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Read
4024
Timeswas read the article
1077
Total PDF
2947
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 35 | 2 | 37 |
| 2025 11 | 157 | 39 | 196 |
| 2025 10 | 87 | 49 | 136 |
| 2025 9 | 84 | 99 | 183 |
| 2025 8 | 97 | 24 | 121 |
| 2025 7 | 94 | 8 | 102 |
| 2025 6 | 46 | 13 | 59 |
| 2025 5 | 62 | 10 | 72 |
| 2025 4 | 72 | 7 | 79 |
| 2025 3 | 44 | 4 | 48 |
| 2025 2 | 58 | 4 | 62 |
| 2025 1 | 38 | 4 | 42 |
| 2024 12 | 30 | 1 | 31 |
| 2024 11 | 26 | 2 | 28 |
| 2024 10 | 24 | 5 | 29 |
| 2024 9 | 26 | 5 | 31 |
| 2024 8 | 29 | 4 | 33 |
| 2024 7 | 27 | 6 | 33 |
| 2024 6 | 24 | 5 | 29 |
| 2024 5 | 22 | 4 | 26 |
| 2024 4 | 37 | 9 | 46 |
| 2024 3 | 15 | 5 | 20 |
| 2024 2 | 44 | 4 | 48 |
| 2024 1 | 30 | 11 | 41 |
| 2023 12 | 22 | 4 | 26 |
| 2023 11 | 30 | 2 | 32 |
| 2023 10 | 51 | 5 | 56 |
| 2023 9 | 42 | 1 | 43 |
| 2023 8 | 28 | 6 | 34 |
| 2023 7 | 24 | 8 | 32 |
| 2023 6 | 38 | 2 | 40 |
| 2023 5 | 51 | 3 | 54 |
| 2023 4 | 56 | 5 | 61 |
| 2023 3 | 35 | 1 | 36 |
| 2023 2 | 28 | 2 | 30 |
| 2023 1 | 40 | 3 | 43 |
| 2022 12 | 46 | 8 | 54 |
| 2022 11 | 39 | 9 | 48 |
| 2022 10 | 19 | 5 | 24 |
| 2022 9 | 16 | 16 | 32 |
| 2022 8 | 13 | 20 | 33 |
| 2022 7 | 20 | 9 | 29 |
| 2022 6 | 15 | 7 | 22 |
| 2022 5 | 17 | 10 | 27 |
| 2022 4 | 26 | 13 | 39 |
| 2022 3 | 24 | 10 | 34 |
| 2022 2 | 32 | 4 | 36 |
| 2022 1 | 15 | 5 | 20 |
| 2021 12 | 17 | 13 | 30 |
| 2021 11 | 12 | 11 | 23 |
| 2021 10 | 14 | 10 | 24 |
| 2021 9 | 11 | 11 | 22 |
| 2021 8 | 7 | 6 | 13 |
| 2021 7 | 11 | 9 | 20 |
| 2021 6 | 7 | 8 | 15 |
| 2021 5 | 14 | 4 | 18 |
| 2021 4 | 16 | 26 | 42 |
| 2021 3 | 10 | 8 | 18 |
| 2021 2 | 17 | 5 | 22 |
| 2021 1 | 11 | 8 | 19 |
| 2020 12 | 12 | 7 | 19 |
| 2020 11 | 10 | 4 | 14 |
| 2020 10 | 11 | 7 | 18 |
| 2020 9 | 17 | 13 | 30 |
| 2020 8 | 13 | 11 | 24 |
| 2020 7 | 10 | 6 | 16 |
| 2020 6 | 9 | 8 | 17 |
| 2020 5 | 11 | 3 | 14 |
| 2020 4 | 13 | 1 | 14 |
| 2020 3 | 9 | 4 | 13 |
| 2020 2 | 7 | 8 | 15 |
| 2020 1 | 10 | 10 | 20 |
| 2019 12 | 16 | 8 | 24 |
| 2019 11 | 5 | 6 | 11 |
| 2019 10 | 6 | 2 | 8 |
| 2019 9 | 9 | 8 | 17 |
| 2019 8 | 7 | 3 | 10 |
| 2019 7 | 11 | 9 | 20 |
| 2019 6 | 28 | 13 | 41 |
| 2019 5 | 57 | 17 | 74 |
| 2019 4 | 29 | 11 | 40 |
| 2019 3 | 9 | 1 | 10 |
| 2019 2 | 13 | 5 | 18 |
| 2019 1 | 8 | 5 | 13 |
| 2018 12 | 4 | 4 | 8 |
| 2018 11 | 9 | 5 | 14 |
| 2018 10 | 4 | 9 | 13 |
| 2018 9 | 4 | 7 | 11 |
| 2018 8 | 2 | 5 | 7 |
| 2018 7 | 4 | 2 | 6 |
| 2018 6 | 3 | 1 | 4 |
| 2018 5 | 5 | 7 | 12 |
| 2018 4 | 1 | 3 | 4 |
| 2018 3 | 7 | 4 | 11 |
| 2018 2 | 4 | 2 | 6 |
| 2018 1 | 10 | 2 | 12 |
| 2017 12 | 9 | 1 | 10 |
| 2017 11 | 10 | 2 | 12 |
| 2017 10 | 21 | 1 | 22 |
| 2017 9 | 10 | 15 | 25 |
| 2017 8 | 12 | 9 | 21 |
| 2017 7 | 16 | 4 | 20 |
| 2017 6 | 10 | 26 | 36 |
| 2017 5 | 12 | 8 | 20 |
| 2017 4 | 18 | 10 | 28 |
| 2017 3 | 10 | 38 | 48 |
| 2017 2 | 15 | 8 | 23 |
| 2017 1 | 16 | 5 | 21 |
| 2016 12 | 19 | 5 | 24 |
| 2016 11 | 17 | 11 | 28 |
| 2016 10 | 49 | 12 | 61 |
| 2016 9 | 46 | 11 | 57 |
| 2016 8 | 29 | 8 | 37 |
| 2016 7 | 33 | 3 | 36 |
| 2016 6 | 58 | 26 | 84 |
| 2016 5 | 54 | 35 | 89 |
| 2016 4 | 14 | 17 | 31 |
Show all